{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T21:17:47Z","timestamp":1768771067537,"version":"3.49.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T00:00:00Z","timestamp":1765065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Key Research and Development Program of China","award":["2017YFC1700606"],"award-info":[{"award-number":["2017YFC1700606"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-04165-9","type":"journal-article","created":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T15:36:13Z","timestamp":1765121773000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A novel cuproptosis-related prognostic gene signature and validation of differential expression in colon cancer"],"prefix":"10.1007","volume":"17","author":[{"given":"Qingya","family":"Song","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zongliang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pingping","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohua","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,7]]},"reference":[{"issue":"3","key":"4165_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"issue":"23","key":"4165_CR2","doi-asserted-by":"publisher","first-page":"3744","DOI":"10.3390\/cells11233744","volume":"11","author":"JP Chuang","year":"2022","unstructured":"Chuang JP, Tsai HL, Chen PJ, et al. Comprehensive review of biomarkers for the treatment of locally advanced colon cancer. Cells. 2022;11(23):3744. https:\/\/doi.org\/10.3390\/cells11233744.","journal-title":"Cells"},{"issue":"2","key":"4165_CR3","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1039\/c6mt00202a","volume":"9","author":"S Blockhuys","year":"2017","unstructured":"Blockhuys S, Celauro E, Hildesj\u00f6 C, et al. Defining the human copper proteome and analysis of its expression variation in cancers. Metallomics. 2017;9(2):112\u201323. https:\/\/doi.org\/10.1039\/c6mt00202a.","journal-title":"Metallomics"},{"issue":"2","key":"4165_CR4","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41568-021-00417-2","volume":"22","author":"EJ Ge","year":"2022","unstructured":"Ge EJ, Bush AI, Casini A, et al. Connecting copper and cancer: from transition metal signalling to metalloplasia. Nat Rev Cancer. 2022;22(2):102\u201313. https:\/\/doi.org\/10.1038\/s41568-021-00417-2.","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"4165_CR5","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.3390\/biomedicines9111628","volume":"9","author":"P Baszuk","year":"2021","unstructured":"Baszuk P, Marciniak W, Derkacz R, et al. Blood copper levels and the occurrence of colorectal cancer in Poland. Biomedicines. 2021;9(11):1628. https:\/\/doi.org\/10.3390\/biomedicines9111628.","journal-title":"Biomedicines"},{"issue":"8","key":"4165_CR6","doi-asserted-by":"publisher","first-page":"852","DOI":"10.3390\/biomedicines9080852","volume":"9","author":"MV Babak","year":"2021","unstructured":"Babak MV, Ahn D. Modulation of intracellular copper levels as the mechanism of action of anticancer copper complexes: clinical relevance. Biomedicines. 2021;9(8):852. https:\/\/doi.org\/10.3390\/biomedicines9080852.","journal-title":"Biomedicines"},{"key":"4165_CR7","doi-asserted-by":"publisher","DOI":"10.1515\/9783110470734-022","author":"D Denoyer","year":"2018","unstructured":"Denoyer D, Clatworthy SAS, Cater MA. Copper complexes in cancer therapy. Met Ions Life Sci. 2018. https:\/\/doi.org\/10.1515\/9783110470734-022.","journal-title":"Met Ions Life Sci"},{"issue":"8","key":"4165_CR8","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/s41423-022-00866-1","volume":"19","author":"Y Wang","year":"2022","unstructured":"Wang Y, Zhang L, Zhou F, Cuproptosis. A new form of programmed cell death. Cell Mol Immunol. 2022;19(8):867\u20138. https:\/\/doi.org\/10.1038\/s41423-022-00866-1.","journal-title":"Cell Mol Immunol"},{"issue":"6586","key":"4165_CR9","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.abf0529","volume":"375","author":"P Tsvetkov","year":"2022","unstructured":"Tsvetkov P, Coy S, Petrova B, et al. Copper induces cell death by targeting lipoylated Tca cycle proteins. Science. 2022;375(6586):1254\u201361. https:\/\/doi.org\/10.1126\/science.abf0529.","journal-title":"Science"},{"key":"4165_CR10","doi-asserted-by":"publisher","first-page":"647152","DOI":"10.3389\/fgene.2021.647152","volume":"12","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Zhu H, Li Q, et al. Gene expression profiling of Tricarboxylic acid cycle and one carbon metabolism related genes for prognostic risk signature of colon carcinoma. Front Genet. 2021;12:647152. https:\/\/doi.org\/10.3389\/fgene.2021.647152.","journal-title":"Front Genet"},{"issue":"9","key":"4165_CR11","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1515\/hsz-2020-0118","volume":"401","author":"M Ren","year":"2020","unstructured":"Ren M, Yang X, Bie J, et al. Citrate synthase desuccinylation by sirt5 promotes colon cancer cell proliferation and migration. Biol Chem. 2020;401(9):1031\u20139. https:\/\/doi.org\/10.1515\/hsz-2020-0118.","journal-title":"Biol Chem"},{"issue":"1","key":"4165_CR12","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1038\/s41467-020-14698-y","volume":"11","author":"Y Liao","year":"2020","unstructured":"Liao Y, Zhao J, Bulek K, et al. Inflammation mobilizes copper metabolism to promote colon tumorigenesis via an il-17-steap4-xiap axis. Nat Commun. 2020;11(1):900. https:\/\/doi.org\/10.1038\/s41467-020-14698-y.","journal-title":"Nat Commun"},{"key":"4165_CR13","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.actbio.2022.08.076","volume":"152","author":"J Li","year":"2022","unstructured":"Li J, Zhang Z, Li J, et al. Copper-olsalazine metal-organic frameworks as a nanocatalyst and epigenetic modulator for efficient Inhibition of colorectal cancer growth and metastasis. Acta Biomater. 2022;152:495\u2013506. https:\/\/doi.org\/10.1016\/j.actbio.2022.08.076.","journal-title":"Acta Biomater"},{"issue":"2","key":"4165_CR14","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1007\/s11356-020-09843-5","volume":"28","author":"M Al-Zharani","year":"2021","unstructured":"Al-Zharani M, Qurtam AA, Daoush WM, et al. Antitumor effect of copper nanoparticles on human breast and colon malignancies. Environ Sci Pollut Res Int. 2021;28(2):1587\u201395. https:\/\/doi.org\/10.1007\/s11356-020-09843-5.","journal-title":"Environ Sci Pollut Res Int"},{"issue":"D1","key":"4165_CR15","doi-asserted-by":"publisher","first-page":"D766","DOI":"10.1093\/nar\/gky955","volume":"47","author":"A Frankish","year":"2019","unstructured":"Frankish A, Diekhans M, Ferreira AM, et al. Gencode reference annotation for the human and mouse genomes. Nucleic Acids Res. 2019;47(D1):D766\u201373. https:\/\/doi.org\/10.1093\/nar\/gky955.","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"4165_CR16","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1111\/j.1349-7006.2012.02367.x","volume":"103","author":"TY Wei","year":"2012","unstructured":"Wei TY, Juan CC, Hisa JY, et al. Protein arginine methyltransferase 5 is a potential oncoprotein that upregulates g1 cyclins\/cyclin-dependent kinases and the phosphoinositide 3-kinase\/akt signaling cascade. Cancer Sci. 2012;103(9):1640\u201350. https:\/\/doi.org\/10.1111\/j.1349-7006.2012.02367.x.","journal-title":"Cancer Sci"},{"issue":"W1","key":"4165_CR17","doi-asserted-by":"publisher","first-page":"W60","DOI":"10.1093\/nar\/gky311","volume":"46","author":"M Franz","year":"2018","unstructured":"Franz M, Rodriguez H, Lopes C, et al. Genemania update 2018. Nucleic Acids Res. 2018;46(W1):W60\u20134. https:\/\/doi.org\/10.1093\/nar\/gky311.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"4165_CR18","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Zhou B, Pache L, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10(1):1523. https:\/\/doi.org\/10.1038\/s41467-019-09234-6.","journal-title":"Nat Commun"},{"issue":"1","key":"4165_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v033.i01","volume":"33","author":"JH Friedman","year":"2010","unstructured":"Friedman JH, Hastie T, et al. Regularization paths for generalized linear models via coordinate descent. J Stat Softw. 2010;33(1):1\u201322. https:\/\/doi.org\/10.18637\/jss.v033.i01.","journal-title":"J Stat Softw"},{"issue":"2","key":"4165_CR20","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","volume":"173","author":"J Liu","year":"2018","unstructured":"Liu J, Lichtenberg T, Hoadley KA, et al. An integrated Tcga pan-cancer clinical data resource to drive high-quality survival outcome analytics. Cell. 2018;173(2):400\u2013e416411. https:\/\/doi.org\/10.1016\/j.cell.2018.02.052.","journal-title":"Cell"},{"issue":"21","key":"4165_CR21","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1158\/0008-5472.Can-17-0307","volume":"77","author":"T Li","year":"2017","unstructured":"Li T, Fan J, Wang B, et al. Timer: A web server for comprehensive analysis of tumor-infiltrating immune cells. Cancer Res. 2017;77(21):e108\u201310. https:\/\/doi.org\/10.1158\/0008-5472.Can-17-0307.","journal-title":"Cancer Res"},{"issue":"5","key":"4165_CR22","doi-asserted-by":"publisher","first-page":"851","DOI":"10.3390\/genes13050851","volume":"13","author":"Z Bian","year":"2022","unstructured":"Bian Z, Fan R, Xie L. A novel Cuproptosis-Related prognostic gene signature and validation of differential expression in clear cell renal cell carcinoma. Genes (Basel). 2022;13(5):851. https:\/\/doi.org\/10.3390\/genes13050851.","journal-title":"Genes (Basel)"},{"key":"4165_CR23","doi-asserted-by":"publisher","first-page":"911316","DOI":"10.3389\/fonc.2022.911316","volume":"12","author":"J Wang","year":"2022","unstructured":"Wang J, Yang Q, Tang M, et al. Validation and analysis of expression, prognosis and immune infiltration of WNT gene family in non-small cell lung cancer. Front Oncol. 2022;12:911316. https:\/\/doi.org\/10.3389\/fonc.2022.911316.","journal-title":"Front Oncol"},{"key":"4165_CR24","doi-asserted-by":"publisher","first-page":"881860","DOI":"10.3389\/fonc.2022.881860","volume":"12","author":"J You","year":"2022","unstructured":"You J, Li H, Wei Y, et al. Novel Pyroptosis-Related gene signatures identified as the prognostic biomarkers for bladder carcinoma. Front Oncol. 2022;12:881860. https:\/\/doi.org\/10.3389\/fonc.2022.881860.","journal-title":"Front Oncol"},{"issue":"1","key":"4165_CR25","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1186\/s40425-019-0810-y","volume":"7","author":"Q Wang","year":"2019","unstructured":"Wang Q, Zhang J, Tu H, et al. Soluble immune checkpoint-related proteins as predictors of tumor recurrence, survival, and t cell phenotypes in clear cell renal cell carcinoma patients. J Immunother Cancer. 2019;7(1):334. https:\/\/doi.org\/10.1186\/s40425-019-0810-y.","journal-title":"J Immunother Cancer"},{"key":"4165_CR26","doi-asserted-by":"publisher","first-page":"952290","DOI":"10.3389\/fonc.2022.952290","volume":"12","author":"H Liu","year":"2022","unstructured":"Liu H, Tang T. Pan-cancer genetic analysis of Cuproptosis and copper metabolism-related gene set. Front Oncol. 2022;12:952290. https:\/\/doi.org\/10.3389\/fonc.2022.952290.","journal-title":"Front Oncol"},{"issue":"1","key":"4165_CR27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40364-022-00446-5","volume":"11","author":"F Bu","year":"2023","unstructured":"Bu F, Li X, Zhao Y, et al. Pan-cancer patterns of Cuproptosis markers reveal biologically and clinically relevant cancer subtypes. Biomark Res. 2023;11(1):13. https:\/\/doi.org\/10.1186\/s40364-022-00446-5.","journal-title":"Biomark Res"},{"issue":"2","key":"4165_CR28","doi-asserted-by":"publisher","first-page":"367","DOI":"10.21037\/jgo-2025-105","volume":"16","author":"J Ma","year":"2025","unstructured":"Ma J, Lin H, Wang Y, et al. The unique role of Cuproptosis in the prognosis and treatment of rectum adenocarcinoma. J Gastrointest Oncol. 2025;16(2):367\u201385. https:\/\/doi.org\/10.21037\/jgo-2025-105.","journal-title":"J Gastrointest Oncol"},{"key":"4165_CR29","doi-asserted-by":"publisher","first-page":"1117164","DOI":"10.3389\/fonc.2023.1117164","volume":"13","author":"Q Zhao","year":"2023","unstructured":"Zhao Q, Qi T. The implications and prospect of cuproptosis-related genes and copper transporters in cancer progression. Front Oncol. 2023;13:1117164. https:\/\/doi.org\/10.3389\/fonc.2023.1117164.","journal-title":"Front Oncol"},{"issue":"1","key":"4165_CR30","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/s41420-025-02535-4","volume":"11","author":"X Wang","year":"2025","unstructured":"Wang X, Guo Y, Fu Y, et al. Acyl post-translational modification of proteins by metabolites in cancer cells. Cell Death Discov. 2025;11(1):247. https:\/\/doi.org\/10.1038\/s41420-025-02535-4.","journal-title":"Cell Death Discov"},{"key":"4165_CR31","doi-asserted-by":"publisher","first-page":"1435651","DOI":"10.3389\/fimmu.2024.1435651","volume":"15","author":"Y Li","year":"2024","unstructured":"Li Y, Sun W, Yuan S, et al. The role of Cuproptosis in gastric cancer. Front Immunol. 2024;15:1435651. https:\/\/doi.org\/10.3389\/fimmu.2024.1435651.","journal-title":"Front Immunol"},{"key":"4165_CR32","doi-asserted-by":"publisher","first-page":"e0205602","DOI":"10.1371\/journal.pone.0205602","volume":"13","author":"S Dhage","year":"2018","unstructured":"Dhage S, Ernlund A, Ruggles K, et al. A genomic ruler to assess oncogenic transition between breast tumor and stroma. PLoS ONE. 2018;13:e0205602. https:\/\/doi.org\/10.1371\/journal.pone.0205602.","journal-title":"PLoS ONE"},{"key":"4165_CR33","doi-asserted-by":"publisher","first-page":"834235","DOI":"10.3389\/fonc.2022.834235","volume":"12","author":"WK Shi","year":"2022","unstructured":"Shi WK, Li YH, Bai XS, et al. The cell Cycle-Associated protein CDKN2A May promotes colorectal cancer cell metastasis by inducing Epithelial-Mesenchymal transition. Front Oncol. 2022;12:834235. https:\/\/doi.org\/10.3389\/fonc.2022.834235.","journal-title":"Front Oncol"},{"key":"4165_CR34","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3390\/biom9030087","volume":"9","author":"R Fontana","year":"2019","unstructured":"Fontana R, Ranieri M, La Mantia G, et al. Dual role of the alternative reading frame ARF protein in cancer. Biomolecules. 2019;9:87. https:\/\/doi.org\/10.3390\/biom9030087.","journal-title":"Biomolecules"},{"issue":"12","key":"4165_CR35","doi-asserted-by":"publisher","first-page":"10512","DOI":"10.18632\/aging.205945","volume":"16","author":"X Cheng","year":"2024","unstructured":"Cheng X, Yang F, Li Y, et al. The crosstalk role of CDKN2A between tumor progression and Cuproptosis resistance in colorectal cancer. Aging. 2024;16(12):10512\u201338. https:\/\/doi.org\/10.18632\/aging.205945.","journal-title":"Aging"},{"issue":"12","key":"4165_CR36","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1038\/bjc.2013.251","volume":"108","author":"X Xing","year":"2013","unstructured":"Xing X, Cai W, Shi H, et al. The prognostic value of cdkn2a hypermethylation in colorectal cancer: A meta-analysis. Br J Cancer. 2013;108(12):2542\u20138. https:\/\/doi.org\/10.1038\/bjc.2013.251.","journal-title":"Br J Cancer"},{"issue":"9","key":"4165_CR37","doi-asserted-by":"publisher","first-page":"13349","DOI":"10.18632\/aging.202962","volume":"13","author":"J Ma","year":"2021","unstructured":"Ma J, Zhong M, Xiong Y, et al. Emerging roles of nucleotide metabolism in cancer development: progress and prospect. Aging. 2021;13(9):13349\u201358. https:\/\/doi.org\/10.18632\/aging.202962.","journal-title":"Aging"},{"issue":"1","key":"4165_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yexcr.2016.05.017","volume":"349","author":"M Weiler","year":"2016","unstructured":"Weiler M, Schmetzer H, Braeu M, et al. Inhibitory effect of extracellular purine nucleotide and nucleoside concentrations on t cell proliferation. Exp Cell Res. 2016;349(1):1\u201314. https:\/\/doi.org\/10.1016\/j.yexcr.2016.05.017.","journal-title":"Exp Cell Res"},{"issue":"1","key":"4165_CR39","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s40425-018-0360-8","volume":"6","author":"RD Leone","year":"2018","unstructured":"Leone RD, Emens LA. Targeting adenosine for cancer immunotherapy. J Immunother Cancer. 2018;6(1):57. https:\/\/doi.org\/10.1186\/s40425-018-0360-8.","journal-title":"J Immunother Cancer"},{"key":"4165_CR40","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s12876-022-02257-2","volume":"22","author":"N Kang","year":"2022","unstructured":"Kang N, Xie X, Zhou X, et al. Identification and validation of EMT-immune-related prognostic biomarkers CDKN2A, CMTM8 and ILK in colon cancer. BMC Gastroenterol. 2022;22:190. https:\/\/doi.org\/10.1186\/s12876-022-02257-2.","journal-title":"BMC Gastroenterol"},{"issue":"22","key":"4165_CR41","doi-asserted-by":"publisher","first-page":"7686","DOI":"10.12998\/wjcc.v10.i22.7686","volume":"10","author":"QQ Wang","year":"2022","unstructured":"Wang QQ, Zhou YC, Zhou Ge YJ, et al. Comprehensive proteomic signature and identification of CDKN2A as a promising prognostic biomarker and therapeutic target of colorectal cancer. World J Clin Cases. 2022;10(22):7686\u201397. https:\/\/doi.org\/10.12998\/wjcc.v10.i22.7686.","journal-title":"World J Clin Cases"},{"issue":"17","key":"4165_CR42","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.2174\/0929867324666170804143706","volume":"26","author":"B Li","year":"2019","unstructured":"Li B, Chan HL, Chen P. Immune checkpoint inhibitors: basics and challenges. Curr Med Chem. 2019;26(17):3009\u201325. https:\/\/doi.org\/10.2174\/0929867324666170804143706.","journal-title":"Curr Med Chem"},{"issue":"7528","key":"4165_CR43","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/nature13954","volume":"515","author":"PC Tumeh","year":"2014","unstructured":"Tumeh PC, Harview CL, Yearley JH, et al. Pd-1 Blockade induces responses by inhibiting adaptive immune resistance. Nature. 2014;515(7528):568\u201371. https:\/\/doi.org\/10.1038\/nature13954.","journal-title":"Nature"},{"issue":"2","key":"4165_CR44","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.cell.2015.03.030","volume":"161","author":"P Sharma","year":"2015","unstructured":"Sharma P, Allison JP. Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential. Cell. 2015;161(2):205\u201314. https:\/\/doi.org\/10.1016\/j.cell.2015.03.030.","journal-title":"Cell"},{"issue":"1","key":"4165_CR45","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/coc.0000000000000239","volume":"39","author":"EI Buchbinder","year":"2016","unstructured":"Buchbinder EI, Desai A. Ctla-4 and pd-1 pathways: Similarities, differences, and implications of their Inhibition. Am J Clin Oncol. 2016;39(1):98\u2013106. https:\/\/doi.org\/10.1097\/coc.0000000000000239.","journal-title":"Am J Clin Oncol"},{"key":"4165_CR46","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","volume":"26","author":"ME Keir","year":"2008","unstructured":"Keir ME, Butte MJ, Freeman GJ, et al. Pd-1 and its ligands in tolerance and immunity. Annu Rev Immunol. 2008;26:677\u2013704. https:\/\/doi.org\/10.1146\/annurev.immunol.26.021607.090331.","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"4165_CR47","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/s41467-017-00799-8","volume":"8","author":"JR Ingram","year":"2017","unstructured":"Ingram JR, Dougan M, Rashidian M et al. (2017). Pd-l1 is an activation-independent marker of brown adipocytes. Nat Commun. 2017;8(1):647. https:\/\/doi.org\/10.1038\/s41467-017-00799-8.","journal-title":"Nat Commun"},{"issue":"6871","key":"4165_CR48","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/415536a","volume":"415","author":"L Monney","year":"2002","unstructured":"Monney L, Sabatos CA, Gaglia JL, et al. Th1-specific cell surface protein tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature. 2002;415(6871):536\u201341. https:\/\/doi.org\/10.1038\/415536a.","journal-title":"Nature"},{"issue":"7865","key":"4165_CR49","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41586-021-03626-9","volume":"595","author":"KO Dixon","year":"2021","unstructured":"Dixon KO, Tabaka M, Schramm MA, et al. Tim-3 restrains anti-tumour immunity by regulating inflammasome activation. Nature. 2021;595(7865):101\u20136. https:\/\/doi.org\/10.1038\/s41586-021-03626-9.","journal-title":"Nature"},{"issue":"2","key":"4165_CR50","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1159\/000490025","volume":"47","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, Yang W, Huang Y, et al. Evolving roles for targeting ctla-4 in cancer immunotherapy. Cell Physiol Biochem. 2018;47(2):721\u201334. https:\/\/doi.org\/10.1159\/000490025.","journal-title":"Cell Physiol Biochem"},{"issue":"4","key":"4165_CR51","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1158\/1078-0432.Ccr-15-1678","volume":"22","author":"JC Dudley","year":"2016","unstructured":"Dudley JC, Lin MT, Le DT, et al. Microsatellite instability as a biomarker for pd-1 Blockade. Clin Cancer Res. 2016;22(4):813\u201320. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-15-1678.","journal-title":"Clin Cancer Res"},{"issue":"8","key":"4165_CR52","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1200\/jco.2017.76.9901","volume":"36","author":"MJ Overman","year":"2018","unstructured":"Overman MJ, Lonardi S, Wong KYM, et al. Durable clinical benefit with nivolumab plus ipilimumab in DNA mismatch repair-deficient\/microsatellite instability-high metastatic colorectal cancer. J Clin Oncol. 2018;36(8):773\u20139. https:\/\/doi.org\/10.1200\/jco.2017.76.9901.","journal-title":"J Clin Oncol"},{"issue":"1","key":"4165_CR53","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1186\/s12885-023-11603-w","volume":"23","author":"Y Dong","year":"2023","unstructured":"Dong Y, Zheng M, Wang X, et al. High expression of CDKN2A is associated with poor prognosis in colorectal cancer and May guide PD-1-mediated immunotherapy. BMC Cancer. 2023;23(1):1097. https:\/\/doi.org\/10.1186\/s12885-023-11603-w.","journal-title":"BMC Cancer"},{"issue":"12","key":"4165_CR54","doi-asserted-by":"publisher","first-page":"357","DOI":"10.31083\/j.fbl2812357","volume":"28","author":"H Zhu","year":"2023","unstructured":"Zhu H, Sun J, Zhang C, et al. Cellular senescence in Non-Small cell lung cancer. Front Biosci (Landmark Ed). 2023;28(12):357. https:\/\/doi.org\/10.31083\/j.fbl2812357.","journal-title":"Front Biosci (Landmark Ed)"},{"key":"4165_CR55","doi-asserted-by":"publisher","first-page":"1486329","DOI":"10.3389\/fimmu.2025.1486329","volume":"16","author":"L Zhang","year":"2025","unstructured":"Zhang L, Guo X, Sun X, et al. Analysis of tumor-infiltrating exhausted T cells highlights IL-6 and PD1 Blockade as a combined immunotherapy strategy for non-small cell lung cancer. Front Immunol. 2025;16:1486329. https:\/\/doi.org\/10.3389\/fimmu.2025.1486329.","journal-title":"Front Immunol"},{"issue":"12","key":"4165_CR56","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1158\/2159-8290.CD-15-1347","volume":"6","author":"BV Park","year":"2016","unstructured":"Park BV, Freeman ZT, Ghasemzadeh A, et al. TGF\u03b21-Mediated SMAD3 enhances PD-1 expression on Antigen-Specific T cells in cancer. Cancer Discov. 2016;6(12):1366\u201381. https:\/\/doi.org\/10.1158\/2159-8290.CD-15-1347.","journal-title":"Cancer Discov"},{"issue":"1","key":"4165_CR57","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13046-024-03050-7","volume":"43","author":"S Wang","year":"2024","unstructured":"Wang S, Li J, Hong S, et al. Chemotherapy-elicited extracellular vesicle CXCL1 from dying cells promotes triple-negative breast cancer metastasis by activating TAM\/PD-L1 signaling. J Exp Clin Cancer Res. 2024;43(1):121. https:\/\/doi.org\/10.1186\/s13046-024-03050-7.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"4165_CR58","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12943-024-02023-w","volume":"23","author":"X Lin","year":"2024","unstructured":"Lin X, Kang K, Chen P, et al. Regulatory mechanisms of PD-1\/PD-L1 in cancers. Mol Cancer. 2024;23(1):108. https:\/\/doi.org\/10.1186\/s12943-024-02023-w.","journal-title":"Mol Cancer"},{"issue":"0","key":"4165_CR59","doi-asserted-by":"publisher","first-page":"11048","DOI":"10.1016\/j.celbio.2025.100148","volume":"0","author":"Z Huang","year":"2025","unstructured":"Huang Z, Li N, Gao Z, et al. Cuproptosis improves CAR-T cell therapy in osteosarcoma. Cell Biomaterials. 2025;0(0):11048. https:\/\/doi.org\/10.1016\/j.celbio.2025.100148.","journal-title":"Cell Biomaterials"},{"key":"4165_CR60","doi-asserted-by":"publisher","first-page":"894315","DOI":"10.3389\/fimmu.2022.894315","volume":"13","author":"KF Chan","year":"2022","unstructured":"Chan KF, Duarte JDG, Ostrouska S, et al. \u03b3\u03b4 T cells in the tumor Microenvironment-Interactions with other immune cells. Front Immunol. 2022;13:894315. https:\/\/doi.org\/10.3389\/fimmu.2022.894315.","journal-title":"Front Immunol"},{"issue":"2","key":"4165_CR61","doi-asserted-by":"publisher","first-page":"e1199","DOI":"10.1002\/ctm2.1199","volume":"13","author":"J Li","year":"2023","unstructured":"Li J, Zhou J, Huang H, et al. Mature dendritic cells enriched in immunoregulatory molecules (mregDCs): A novel population in the tumour microenvironment and immunotherapy target. Clin Transl Med. 2023;13(2):e1199. https:\/\/doi.org\/10.1002\/ctm2.1199.","journal-title":"Clin Transl Med"},{"issue":"19","key":"4165_CR62","doi-asserted-by":"publisher","first-page":"4755","DOI":"10.3390\/cancers14194755","volume":"14","author":"W Zheng","year":"2022","unstructured":"Zheng W, Wu J, Peng Y, et al. Tumor-Associated neutrophils in colorectal cancer Development, progression and immunotherapy. Cancers (Basel). 2022;14(19):4755. https:\/\/doi.org\/10.3390\/cancers14194755.","journal-title":"Cancers (Basel)"},{"key":"4165_CR63","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/s41423-023-01061-6","volume":"20","author":"M Bied","year":"2023","unstructured":"Bied M, Ho WW, Ginhoux F, et al. Roles of macrophages in tumor development: a Spatiotemporal perspective. Cell Mol Immunol. 2023;20:983\u201392. https:\/\/doi.org\/10.1038\/s41423-023-01061-6.","journal-title":"Cell Mol Immunol"},{"key":"4165_CR64","doi-asserted-by":"publisher","first-page":"108429","DOI":"10.1016\/j.clim.2020.108429","volume":"215","author":"S Khalaf","year":"2020","unstructured":"Khalaf S, Toor SM, Murshed K, et al. Differential expression of tim-3 in circulation and tumor microenvironment of colorectal cancer patients. Clin Immunol. 2020;215:108429. https:\/\/doi.org\/10.1016\/j.clim.2020.108429.","journal-title":"Clin Immunol"},{"key":"4165_CR65","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.3389\/fonc.2020.01288","volume":"10","author":"S Qin","year":"2020","unstructured":"Qin S, Dong B, Yi M, et al. Prognostic values of tim-3 expression in patients with solid tumors: A meta-analysis and database evaluation. Front Oncol. 2020;10:1288. https:\/\/doi.org\/10.3389\/fonc.2020.01288.","journal-title":"Front Oncol"},{"issue":"6","key":"4165_CR66","doi-asserted-by":"publisher","first-page":"8509","DOI":"10.1002\/jcp.27782","volume":"234","author":"B Farhood","year":"2019","unstructured":"Farhood B, Najafi M, Mortezaee K. Cd8(+) cytotoxic t lymphocytes in cancer immunotherapy: A review. J Cell Physiol. 2019;234(6):8509\u201321. https:\/\/doi.org\/10.1002\/jcp.27782.","journal-title":"J Cell Physiol"},{"issue":"5","key":"4165_CR67","doi-asserted-by":"publisher","first-page":"149","DOI":"10.4155\/ppa-2020-0017","volume":"9","author":"M Perez-Santos","year":"2020","unstructured":"Perez-Santos M. Bispecific anti-pd-1\/ctla-4 antibody for advanced solid tumors. Pharm Pat Anal. 2020;9(5):149\u201354. https:\/\/doi.org\/10.4155\/ppa-2020-0017.","journal-title":"Pharm Pat Anal"},{"key":"4165_CR68","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ctrv.2017.11.007","volume":"63","author":"R Tokunaga","year":"2018","unstructured":"Tokunaga R, Zhang W, Naseem M, et al. CXCL9, CXCL10, CXCL11\/CXCR3 axis for immune activation - A target for novel cancer therapy. Cancer Treat Rev. 2018;63:40\u20137. https:\/\/doi.org\/10.1016\/j.ctrv.2017.11.007.","journal-title":"Cancer Treat Rev"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-04165-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-04165-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-04165-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T22:19:59Z","timestamp":1768342799000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-04165-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,7]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4165"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-04165-9","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,7]]},"assertion":[{"value":"29 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All data for this study were obtained from public databases, which were already reviewed and approved by their respective ethical review boards. Therefore, this study did not require new ethical review board approval. This article is not a clinical study, so it is not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This article is not a clinical study, so it is not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"66"}}